TearSolutions, Inc.

TearSolutions’ proprietary protein is to Dry Eye Disease as insulin is to Type I Diabetes. Our lead product is well-poised to disrupt the $6B+ Dry Eye market.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Charlottesville, VA, USA
  • Currency USD
  • Founded July 2014
  • Employees 6
  • Incorporation Type C-corp
  • Website tearsolutions.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free